Repare Therapeutics Inc.
RPTX
$1.36
$0.118.80%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 152.79M | 179.43M | 208.12M | 237.00M | 223.63M |
| Total Receivables | 12.35M | 14.23M | 14.64M | 14.21M | 15.31M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.01M | 6.74M | 5.77M | 3.46M | 4.75M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 171.15M | 200.40M | 228.54M | 254.67M | 243.69M |
|
|
|||||
| Total Current Assets | 171.15M | 200.40M | 228.54M | 254.67M | 243.69M |
| Net Property, Plant & Equipment | 4.22M | 5.22M | 5.42M | 6.48M | 7.54M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.14M | 765.00K | 1.38M | 1.94M | 2.67M |
| Total Assets | 176.51M | 206.39M | 235.34M | 263.08M | 253.90M |
|
|
|||||
| Total Accounts Payable | 3.62M | 10.66M | 7.18M | 6.83M | 2.40M |
| Total Accrued Expenses | 19.65M | 17.68M | 21.98M | 19.85M | 23.86M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.85M | 2.22M | 1.96M | 2.22M | 2.40M |
| Total Finance Division Other Current Liabilities | 166.00K | 530.00K | 335.00K | 1.67M | 10.42M |
| Total Other Current Liabilities | 166.00K | 530.00K | 335.00K | 1.67M | 10.42M |
| Total Current Liabilities | 25.29M | 31.08M | 31.45M | 30.57M | 39.08M |
|
|
|||||
| Total Current Liabilities | 25.29M | 31.08M | 31.45M | 30.57M | 39.08M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 88.00K | 346.00K | 218.00K | 561.00K | 1.01M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 1.73M |
| Total Liabilities | 25.38M | 31.43M | 31.67M | 31.13M | 41.82M |
|
|
|||||
| Common Stock & APIC | 568.87M | 563.95M | 558.53M | 552.01M | 545.16M |
| Retained Earnings | -417.80M | -389.13M | -354.72M | -319.95M | -333.11M |
| Treasury Stock & Other | 64.00K | 140.00K | -134.00K | -113.00K | 28.00K |
| Total Common Equity | 151.13M | 174.96M | 203.68M | 231.95M | 212.08M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 151.13M | 174.96M | 203.68M | 231.95M | 212.08M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 151.13M | 174.96M | 203.68M | 231.95M | 212.08M |
|
|
|||||